Joachim G.J.V. Aerts

2 ta ish

Erasmus University Rotterdam

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.170111

2. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

   Harry J. de Koning, Carlijn M. van der Aalst, Pim A. de Jong +21

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.277951